ARCHIVES

Animas As Early Warning “Sentinels” Part Of DCE Study

This article is from The Cancer Letter archive.

Vol. 13 No. 31 | July 31, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: GAO Says Congress Should Re-Examine Delaney Clause, Consider Making It More Flexible

January 8, 1982

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

NCAB Approves Concept Of Four Contract Program

May 29, 1981

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

Final Issue Of the Year

December 14, 1990

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993